☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Confo Therapeutics Entered into a Global License Agreement with Eli Lilly for CFTX-1554
March 2, 2023
Zack Usilton, Chief Development Officer at Senta Partners Shares Insights from their Partnership with Reston ENT to Expand its Net...
March 2, 2023
Should You Be Considering Dental Cosmetic Surgeries
March 2, 2023
Biogen Launches Byooviz (biosimilar, ranibizumab) for the Treatment of Retinal Disorders in Canada
March 2, 2023
Sanofi and Sobi Report P-III Study (XTEND-Kids) Results of Altuviiio for the Treatment of Hemophilia A in Children Aged <12 Years
March 2, 2023
ImmunoGen Signs a Multi-Target License and Option Agreement with Vertex to Develop Novel Targeted Conditioning Agents
March 2, 2023
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions